G
Gary D.V. Hankins
Researcher at University of Texas Medical Branch
Publications - 347
Citations - 15976
Gary D.V. Hankins is an academic researcher from University of Texas Medical Branch. The author has contributed to research in topics: Pregnancy & Placenta. The author has an hindex of 59, co-authored 346 publications receiving 14203 citations. Previous affiliations of Gary D.V. Hankins include Society for Maternal-Fetal Medicine & Oregon Health & Science University.
Papers
More filters
Journal ArticleDOI
Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes: NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes
Larry C. Gilstrap,Robert Christensen,William H. Clewell,Mary E. D'Alton,Ezra C. Davidson,Marilyn B. Escobedo,Dwenda K. Gjerdingen,Jan Goddard-Finegold,Robert L. Goldenberg,David A. Grimes,Thomas N. Hansen,Ralph E. Kauffman,Emmett B. Keeler,William Oh,Elizabeth J. Susman,Marlyn G. Vogel,Mary Ellen Avery,Philip L. Ballard,Roberta A. Ballard,Patricia Crowley,Thomas J. Garite,Gary D.V. Hankins,Alan H. Jobe,Janna G. Koppe,James Maher,Irwin R. Merkatz,Seetha Shankaran,Kit N. Simpson,John C. Sinclair,Theodore A. Slotkin,H. William Taeusch,Linda L. Wright,Duane F. Alexander,Mary Anne Berberich,Michael B. Bracken,Leslie T. Cooper,Larry Culpepper,Jerry M. Elliott,John H. Ferguson,Frederic Frigoletto,Dorothy Berlin Gail,William H. Hall,M. Douglas Jones,Barbara Medoff-Cooper,Gerald B. Merenstein,Judith M. Whalen,Claude Lenfant,Ada Sue Hinshaw +47 more
TL;DR: Antenatal corticosteroid therapy is indicated for women at risk of premature delivery with few exceptions and will result in a substantial decrease in neonatal morbidity and mortality, as well as substantial savings in health care costs.
Journal ArticleDOI
A Randomized, Controlled Trial of Magnesium Sulfate for the Prevention of Cerebral Palsy
Dwight J. Rouse,Deborah Hirtz,Elizabeth Thom,Michael W. Varner,Catherine Y. Spong,Brian M. Mercer,Brian M. Mercer,Jay D. Iams,Ronald J. Wapner,Ronald J. Wapner,Yoram Sorokin,James M. Alexander,Margaret Harper,John M. Thorp,Susan M. Ramin,Fergal D. Malone,Marshall W. Carpenter,Menachem Miodovnik,Atef H. Moawad,Mary Jo O'Sullivan,Alan M. Peaceman,Gary D.V. Hankins,Oded Langer,Steve N. Caritis,James M. Roberts +24 more
TL;DR: Fetal exposure to magnesium sulfate before anticipated early preterm delivery did not reduce the combined risk of moderate or severe cerebral palsy or death, although the rate of cerebral palsies was reduced among survivors.
Journal ArticleDOI
First-trimester maternal serum PAPP-A and free-beta subunit human chorionic gonadotropin concentrations and nuchal translucency are associated with obstetric complications: A population-based screening study (The FASTER Trial)
Lorraine Dugoff,John C. Hobbins,Fergal D. Malone,T. Flint Porter,David A. Luthy,Christine H. Comstock,Gary D.V. Hankins,Richard L. Berkowitz,Irwin R. Merkatz,Sabrina D. Craigo,Ilan E. Timor-Tritsch,Steven R. Carr,Honor M. Wolfe,John Vidaver,Mary E. D'Alton +14 more
TL;DR: Low pregnancy-associated plasma protein A levels in the first trimester were associated strongly with a number of adverse pregnancy outcomes, and low free-beta subunit human chorionic gonadotropin levels and large nuchal translucency were both associated with early fetal loss.
Journal ArticleDOI
The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines.
TL;DR: A discussion of terminology and nomenclature for the description of fetal heart tracings and uterine contractions for use in clinical practice and research and a three-tier system for fetal heart rate tracing interpretation are described.
Journal ArticleDOI
Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery.
Steven L. Clark,Michael A. Belfort,Gary A. Dildy,Melissa A. Herbst,Janet A. Meyers,Gary D.V. Hankins +5 more
TL;DR: Most maternal deaths are not preventable, given the diversity of causes of maternal death, and no systematic reduction in maternal death rate in the United States can be expected unless all women undergoing cesarean delivery receive thromboembolism prophylaxis.